The DTx adoption tipping point is closer than payers and the broader healthcare industry may realize. In the wake of the COVID-19 crisis, the pace of digital health transformation is accelerating on a massive scale.
Chronic disease makes up a major portion of the total healthcare spend in the U.S. and globally, driving the development of increasingly advanced, AI-supported digital therapeutic solutions for chronic disease managment.
